In view of the association of congenital heart blockwith maternal antibody to ceilular antigen Ro (SSA), and one report linking anti-Ro with myocarditis in a patient with myositis an association between anti-Ro antibodies and cardiac disease was sought in adults with systemic lupus erythematosus (SLE). Among 67 patients with SLE, of whom 36 were antiRo positive, a significantly higher prevalence of myocarditis and conduction defects was found in the anti-Ro positive group (eight of 36) than in those who were anti-Ro negative (one of 31) and healthy controls (one of 50). Of the 36 anti-Ro positive patients with SLE, three had symptoms diagnostic ofmyocarditis, and an electrocardiogram showed first degree atrioventricular block and unifascicular block in three cases (including one with myocarditis), right bundle branch block alone (two cases), and first degree atrioventricular block alone (one case). Complete atrioventricular block was not seen. In the anti-Ro negative group there was no myocarditis and only one case of conduction defect (right bundle branch block). Among healthy controls only one of 50 had first degree atrioventricular block.
The presence of anti-Ro (SSA) antibodies in adults with systemic lupus erythematosus (SLE) has been associated with different subsets of the disease, including subacute cutaneous lupus erythematosus, antinuclear antibody negative lupus, and the lupus like disease of homozygous C2 and C4 deficiency. '`Since the first report of myocardial disease in neonatal lupus erythematosus was published by
McCuiston and Schoch in 19540 several articles have reported the association between SLE and anti-Ro or anti-La autoantibodies and myocardial disease.5'2 Although Maier reported on a patient with SLE who had complete heart block as the first manifestation of the disease,'3 the possible association between antibodies to Ro or La and myocarditis or heart conduction defects in adults with SLE remains unclear. The purpose of this study was to determine the following: (i) the association between the presence of anti-Ro autoantibodies and myocarditis or cardiac conduction defects in adults with SLE; and (ii) possible HLA markers in such patients with myocarditis or cardiac conduction defects. 21 Serological findings and the results of clinical and cardiac examinations obtained on each visit to the department were processed on an IBM PC computer and tested for significance with the x2 analysis using the statistical package for the social sciences (SPSS)/PC+ program.
Results
The group of 36 anti-Ro positive patients was divided into several subgroups according to the presence ofother anti-extractable nuclear antigen antibodies. Eighteen patients had only anti-Ro antibodies and five had antibodies to Ro and La. We detected anti-Ro together with other autoantibodies to extractable nuclear antigens in 13 serum samples: U1-RNP in five; Sm in three; SL in two; and antibodies to unidentified antigens in five (table 1) . Among anti-Ro negative patients, 22 were completely anti-Logar, Kveder, Rozman, Dobovisek 29 Complete heart block was not found in any of our 36 anti-Ro positive patients, but Maier reported one patient with anti-Ro antibody in whom complete heart block was the first manifestation of SLE. 13 Provost suggested that expression of Ro antigen is more pronounced in the fetal heart, but membrane expression may be the relevant factor. 35 Our results indicate that anti-Ro antibody 
